David Hoang
Stock Analyst at Deutsche Bank
(1.88)
# 3,079
Out of 4,876 analysts
40
Total ratings
40%
Success rate
-8.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Hoang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Hold | $50 → $25 | $17.04 | +46.71% | 7 | Jun 17, 2025 | |
| ACAD ACADIA Pharmaceuticals | Upgrades: Buy | $20 → $35 | $21.83 | +60.37% | 5 | May 21, 2025 | |
| ALKS Alkermes | Maintains: Buy | $40 → $52 | $28.67 | +81.37% | 2 | Mar 27, 2025 | |
| XENE Xenon Pharmaceuticals | Initiates: Buy | $67 | $32.22 | +107.98% | 3 | Feb 11, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $111 | $43.08 | +157.69% | 1 | Feb 11, 2025 | |
| HRMY Harmony Biosciences Holdings | Initiates: Buy | $55 | $31.63 | +73.89% | 2 | Feb 11, 2025 | |
| DNLI Denali Therapeutics | Initiates: Buy | $31 | $14.19 | +118.46% | 3 | Feb 11, 2025 | |
| BHVN Biohaven | Initiates: Buy | $65 | $14.16 | +359.04% | 1 | Feb 11, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $176 | $104.71 | +68.09% | 4 | Feb 11, 2025 | |
| AVDL Avadel Pharmaceuticals | Initiates: Buy | $12 | $8.97 | +33.78% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $150 → $158 | $126.25 | +25.14% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.17 | +498.29% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $8 | $9.26 | -13.61% | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.69 | +241.15% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $2.88 | +456.52% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $220 | $320.03 | -31.26% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $80 | $15.99 | +400.31% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 | $1.26 | +139.04% | 1 | Dec 7, 2022 |
Sarepta Therapeutics
Jun 17, 2025
Maintains: Hold
Price Target: $50 → $25
Current: $17.04
Upside: +46.71%
ACADIA Pharmaceuticals
May 21, 2025
Upgrades: Buy
Price Target: $20 → $35
Current: $21.83
Upside: +60.37%
Alkermes
Mar 27, 2025
Maintains: Buy
Price Target: $40 → $52
Current: $28.67
Upside: +81.37%
Xenon Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $67
Current: $32.22
Upside: +107.98%
Praxis Precision Medicines
Feb 11, 2025
Initiates: Buy
Price Target: $111
Current: $43.08
Upside: +157.69%
Harmony Biosciences Holdings
Feb 11, 2025
Initiates: Buy
Price Target: $55
Current: $31.63
Upside: +73.89%
Denali Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $31
Current: $14.19
Upside: +118.46%
Biohaven
Feb 11, 2025
Initiates: Buy
Price Target: $65
Current: $14.16
Upside: +359.04%
Axsome Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $176
Current: $104.71
Upside: +68.09%
Avadel Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $12
Current: $8.97
Upside: +33.78%
Aug 2, 2024
Maintains: Neutral
Price Target: $150 → $158
Current: $126.25
Upside: +25.14%
Jul 25, 2024
Initiates: Buy
Price Target: $7
Current: $1.17
Upside: +498.29%
May 29, 2024
Initiates: Sell
Price Target: $8
Current: $9.26
Upside: -13.61%
Mar 15, 2024
Initiates: Buy
Price Target: $16
Current: $4.69
Upside: +241.15%
Mar 7, 2024
Initiates: Buy
Price Target: $16
Current: $2.88
Upside: +456.52%
Apr 26, 2023
Initiates: Neutral
Price Target: $220
Current: $320.03
Upside: -31.26%
Apr 26, 2023
Initiates: Outperform
Price Target: $80
Current: $15.99
Upside: +400.31%
Dec 7, 2022
Downgrades: Neutral
Price Target: $3
Current: $1.26
Upside: +139.04%